31P The IOpener study: Tyrosine kinase activity profiling to predict response to immune checkpoint inhibitors in patients with advanced stage non-small cell lung cancer. (December 2022) - Joode, K.D.; Groen, H.J.M.; van den Heuvel, M.; Kloover, J.S.; van der Meer, F.; Stigt, J.A.; van der Leest, C.H.; Van Den Borne, B.; de Wijn, R.; Hurkmans, D.P.; van den Heuvel, D.M.A.; van Doorn, T.; et al.